
Cairdac
CAIRDAC is developing the first autonomous leadless pacemaker incorporating energy harvesting capabilities that synchronizes with the heart’s rhythm to produce kinetic energy, which powers the device with no energy limitation.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
* | €17.0m | Series A | |
Total Funding | 000k |
EUR | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Cairdac is at the forefront of medical technology, focusing on the development of the ALPS device, a leadless and self-sustaining cardiac pacemaker. This device is designed to address the limitations of traditional pacemakers by utilizing a patented energy harvester technology, which ensures longer device life and reduced energy consumption. Cairdac's primary market includes patients and healthcare professionals seeking advanced cardiac pacing solutions. The business model revolves around creating cost-effective, life-saving medical devices that streamline healthcare processes. Although the ALPS devices are not currently available for sale, the company aims to revolutionize cardiac care with its innovative approach. Cairdac generates revenue through the development and eventual sale of its medical devices, targeting healthcare institutions and professionals who require cutting-edge solutions for cardiac pacing.
Keywords: cardiac, pacemaker, leadless, self-sustaining, energy harvester, healthcare, patients, medical device, ALPS, cardiac pacing.